Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Abstract:||Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, X and n are as defined in the claims and the pharmaceutically acceptable salts thereof are new. These compounds are useful psychotherapeutics and are potent serotonin (5-HT.sub.1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting hypertensives and vasodilators. A process for forming indoles by transition metal catalyzed cyclization of dihalogenated intermediate is also disclosed.|
|Inventor(s):||Macor; John E. (New York, NY)|
|Assignee:||Pfizer Inc. (New York, NY)|
|Filing Date:||Jun 06, 1995|
|Claims:||1. A process for preparing a compound of the formula ##STR77## wherein X is chlorine, bromine, or iodine; A is a first suitable nitrogen protecting group; R.sub.15 is hydrogen, halogen, cyano, --OR.sub.16, --(CH.sub.2).sub.m --(C.dbd.O)NR.sub.17 R.sub.18, --(CH.sub.2).sub.m --SO.sub.2 NR.sub.17 R.sub.18, --(CH.sub.2).sub.m --NR.sub.19 (C.dbd.O)R.sub.20, --(CH.sub.2).sub.m --NR.sub.19 SO.sub.2 R.sub.20, --(CH.sub.2).sub.m --S(O).sub.x R.sub.20, --(CH.sub.2).sub.m --NR.sub.19 (C.dbd.O)NR.sub.17 R.sub.18, --(CH.sub.2).sub.m --NR.sub.19 (C.dbd.O)OR.sub.21, --CH.dbd.CH(CH.sub.2).sub.y R.sub.22, --(CH.sub.2).sub.m --T, and a substituent of the formula ##STR78## B represents a direct bond, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.4 alkenyl; D, E, G, and J are each independently oxygen, sulfur, nitrogen or carbon, provided that at least one of D, E, G, and J is nitrogen; R.sub.28, R.sub.29, R.sub.30, and R.sub.31 are each independently hydrogen, C.sub.1 -C.sub.6 alkyl, aryl, C.sub.1 -C.sub.3 alkylaryl, C.sub.1 -C.sub.3 alkylheteroaryl, halogen, cyano, trifluoromethyl, nitro, --OR.sub.32, --NR.sub.32 R.sub.33, --(CH.sub.2).sub.m OR.sub.32, --SR.sub.32, --SO.sub.2 NR.sub.32 R.sub.33, --NR.sub.32 SO.sub.2 R.sub.33, --NR.sub.32 CO.sub.2 R.sub.33, --CONR.sub.32 R.sub.33, or --CO.sub.2 R.sub.32 ; one of R.sub.28 and R.sub.29, R.sub.29 and R.sub.30, or R.sub.30 and R.sub.31 may be taken together to form a five- to seven-membered alkyl ring, a six-membered aryl ring, a five- to seven-membered heteroalkyl ring having 1 heteroatom of N, O, or S, or a five- to six-membered heteroaryl ring having 1 or 2 heteroatoms of N, O, or S; R.sub.32 and R.sub.33 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, --(CH.sub.2).sub.q R.sub.34, C.sub.1 to C.sub.3 alkylaryl, or aryl; R.sub.32 and R.sub.33 may be taken together to form a C.sub.4 -C.sub.7 alkyl ring; R.sub.34 is cyano, trifluoromethyl, or C.sub.1 -C.sub.4 alkoxy; R.sub.16 is selected from hydrogen, C.sub.1 to C.sub.6 alkyl, and aryl; T is ##STR79## M and Q are each independently oxygen or sulfur; Z is --O--, --S--, --NH, or --CH.sub.2 ; R.sub.35 and R.sub.36 are each independently hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, C.sub.1 to C.sub.3 alkylaryl, or C.sub.1 to C.sub.3 alkylheteroaryl; R.sub.22 is selected from --(C.dbd.O)NR.sub.23 R.sub.24, --SO.sub.2 NR.sub.23 R.sub.24, --NR.sub.25 (C.dbd.O)R.sub.26, --NR.sub.25 SO.sub.2 R.sub.26, --NR.sub.25 (C.dbd.O)NR.sub.23 R.sub.24, --S(O).sub.x R.sub.26 and --NR.sub.7 (C.dbd.O)OR.sub.27 ; R.sub.17, R.sub.18, R.sub.23, and R.sub.24 are independently selected from hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, and C.sub.1 to C.sub.3 alkyl-aryl, or R.sub.17 and R.sub.18 or R.sub.23 and R.sub.24 maybe taken together to form a 4, 5, or 6 membered ring; R.sub.19, R.sub.20, R.sub.21, R.sub.25, R.sub.26, and R.sub.27 are independently selected from hydrogen, C.sub.1 to C.sub.6 alkyl, aryl, and C.sub.1 to C.sub.3 alkyl-aryl; y is 0, 1, or 2; x is 1 or 2; m is 0, 1, 2, or 3; n is 1; q is 1, 2, or 3; a chiral carbon designated by #; and the above aryl groups and the aryl moieties of the above alkylaryl groups are independently selected from phenyl and substituted phenyl, wherein said substituted phenyl may be substituted with one to three groups selected from C.sub.1 to C.sub.4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, and C.sub.1 to C.sub.4 alkoxy, |
comprising, performing a transition metal catalyzed cyclization on a compound of the formula ##STR80## wherein A and R.sub.15 are as defined above and V is a second suitable nitrogen protecting group.
2. The process of claim 1, wherein X is bromine.
3. The process of claim 1, wherein A is benzyloxycarbonyl.
4. The process of claim 1, wherein V is trifluoroacetyl.